TokenPost·
Pelthos Targets Xepi Promotion to Current Customers by End of Q1 2027

The company has a separate first-quarter 2027 target for Xepi’s launch. Its proposed merger with Castle Creek Biosciences is expected to close by the end of the quarter, pending approval and other conditions.